Article
Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology - 1 Apr 2021
García-García Ana, Buendia Arellano Monserrat, Deyà-Martínez Àngela, Lozano Blasco Jaime, Serrano Mercedes, Van Den Rym Ana, García-Solis Blanca, Esteve-Solé Ana, Yiyi Luo, Vlagea Alexandru, Solanich Xavier, Fisher Megan R, Lyons Jonathan J, de Diego Rebeca Pérez, Alsina Laia
Abstract excerpt
BACKGROUND: Phosphoglucomutase-3 (PGM3) deficiency is a congenital disorder of glycosylation (CDG) with hyperimmunoglobulin IgE, atopy, and a variable immunological phenotype; most reported patients display dysmorphic features. The aim of the study was to characterize the genotype and phenotype of individuals with newly identified compound heterozygous variants in the phosphate-binding domain of PGM3 in order to...
Topics
Join the communities discussing this publication.
